Evidence map›Paper›PMID 26367394›Full record

ArticlePLoS pathogens2015

Neisseria meningitidis Type IV Pili Composed of Sequence Invariable Pilins Are Masked by Multisite Glycosylation.

Joseph Gault, Mathias Ferber, Silke Machata, Anne-Flore Imhaus, Christian Malosse, Arthur Charles-Orszag, Corinne Millien, Guillaume Bouvier, Benjamin Bardiaux, Gérard Péhau-Arnaudet and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Top-down proteomics.Nature reviews. Methods primers · 2024
    Article
  8. Sweet complexity:Frontiers in cellular and infection microbiology · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Host-Pathogen Interactions and Epicellular Lifestyle ofFrontiers in cellular and infection microbiology · 2022
    Review
  14. Article
  15. Lactate-Induced Dispersal ofInfection and immunity · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 2 countries.

Joseph GaultStructural Mass Spectrometry and Proteomics Unit, Institut Pasteur, CNRS UMR 3528, Paris, France.
Mathias FerberInstitut Pasteur, Unité de Bioinformatique Structurale, CNRS UMR 3528, Département de Biologie Structurale et Chimie, Paris, France.
Silke MachataINSERM, U970, Paris Cardiovascular Research Center, Paris, France; Université Paris Descartes, Faculté de Médecine Paris Descartes, Paris, France.
Anne-Flore ImhausINSERM, U970, Paris Cardiovascular Research Center, Paris, France; Université Paris Descartes, Faculté de Médecine Paris Descartes, Paris, France.
Christian MalosseStructural Mass Spectrometry and Proteomics Unit, Institut Pasteur, CNRS UMR 3528, Paris, France.
Arthur Charles-OrszagINSERM, U970, Paris Cardiovascular Research Center, Paris, France; Université Paris Descartes, Faculté de Médecine Paris Descartes, Paris, France.
Corinne MillienINSERM, U970, Paris Cardiovascular Research Center, Paris, France; Université Paris Descartes, Faculté de Médecine Paris Descartes, Paris, France.
Guillaume BouvierInstitut Pasteur, Unité de Bioinformatique Structurale, CNRS UMR 3528, Département de Biologie Structurale et Chimie, Paris, France.
Benjamin BardiauxInstitut Pasteur, Unité de Bioinformatique Structurale, CNRS UMR 3528, Département de Biologie Structurale et Chimie, Paris, France.
Gérard Péhau-ArnaudetCNRS, UMR3528, Paris, France.
Kelly KlingeDepartment of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
Isabelle PodglajenService de Microbiologie, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Paris, France.
Marie Cécile PloyINSERM UMR1092, Faculté de Médecine, Université de Limoges, Limoges, France.
H Steven SeifertDepartment of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
Michael NilgesInstitut Pasteur, Unité de Bioinformatique Structurale, CNRS UMR 3528, Département de Biologie Structurale et Chimie, Paris, France.
Julia Chamot-RookeStructural Mass Spectrometry and Proteomics Unit, Institut Pasteur, CNRS UMR 3528, Paris, France.
Guillaume DuménilINSERM, U970, Paris Cardiovascular Research Center, Paris, France; Université Paris Descartes, Faculté de Médecine Paris Descartes, Paris, France.
Institut Pasteur · FRCentre National de la Recherche Scientifique · FRDélégation Paris 5 · FRNorthwestern University · USAssistance Publique – Hôpitaux de Paris · FRInserm · FRParis Cardiovascular Research Center · FRUniversité de Limoges · FRUniversité Paris Cité · FR

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
Mechanisms of Gonococcal Pilin Antigenic/Phase VariationR37AI033493 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Hank S. SEIFERT · 2003 to 2026
$10.1M
Molecular Genetics of the GonococcusR01AI044239 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SEIFERT, HANK S. · 1999 to 2014
$4.0M
Assembly and Function of the Gonococcal PilusR56AI114821 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SEIFERT, HANK S. · 2015 to 2015
$309k
NCI NIH HHS P30 CA060553NIAID NIH HHS R01 AI044239NIAID NIH HHS R37 AI033493NIAID NIH HHS R56 AI114821Wellcome TrustWellcome Trust WT093470AIA
6 · The paper itself

Abstract

The ability of pathogens to cause disease depends on their aptitude to escape the immune system. Type IV pili are extracellular filamentous virulence factors composed of pilin monomers and frequently expressed by bacterial pathogens. As such they are major targets for the host immune system. In the human pathogen Neisseria meningitidis, strains expressing class I pilins contain a genetic recombination system that promotes variation of the pilin sequence and is thought to aid immune escape. However, numerous hypervirulent clinical isolates express class II pilins that lack this property. This raises the question of how they evade immunity targeting type IV pili. As glycosylation is a possible source of antigenic variation it was investigated using top-down mass spectrometry to provide the highest molecular precision on the modified proteins. Unlike class I pilins that carry a single glycan, we found that class II pilins display up to 5 glycosylation sites per monomer on the pilus surface. Swapping of pilin class and genetic background shows that the pilin primary structure determines multisite glycosylation while the genetic background determines the nature of the glycans. Absence of glycosylation in class II pilins affects pilus biogenesis or enhances pilus-dependent aggregation in a strain specific fashion highlighting the extensive functional impact of multisite glycosylation. Finally, molecular modeling shows that glycans cover the surface of class II pilins and strongly decrease antibody access to the polypeptide chain. This strongly supports a model where strains expressing class II pilins evade the immune system by changing their sugar structure rather than pilin primary structure. Overall these results show that sequence invariable class II pilins are cloaked in glycans with extensive functional and immunological consequences.

Indexed as

Immune EvasionModels, MolecularProtein Processing, Post-TranslationalAmino Acid SequenceBacterial AdhesionCell LineCells, CulturedConserved SequenceEndothelium, VascularFimbriae, BacterialFimbriae ProteinsGene DeletionGlycosylationHost-Pathogen InteractionsHumansHuman Umbilical Vein Endothelial CellsFimbriae Proteins

Identifiers

PMID26367394
PMCPMC4569582
OpenAlexW1867284802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.